We came across a bullish thesis on Innoviva, Inc on Deep-Value Stocks’s Substack. In this article, we will summarize the bulls’ thesis on INVA. Innoviva, Inc's share was trading at $22.48 as of February 11th. INVA’s trailing and forward P/E were 13.54 and 10.83 respectively according to Yahoo Finance.
[caption id="attachment_557900" align="aligncenter" width="750"]Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. INVA presents a compelling investment...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.